PEMBROLIZUMAB, ATEZOLIZUMAB, NIVOLUMAB, CEMIPLIMAB clinical trials

Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)

This study, called ICONIC, is looking at how a combination of powerful cancer medications and a special type of radiation therapy called carbon ion radiotherapy works for certain solid cancers that haven't responded to other treatments. We want to see if this combination can shrink tumours and improve patients' health.